Test Entry - Detail

Rapid Aneuploidy Analysis


General
  Clinical Use: The Aneuploidy Screen, using molecular methods (QF-PCR), is a rapid screening technique that supplements the traditional cytogenetic methods assessing amniotic fluid samples for chromosomal abnormalities during the first trimester of pregnancy.
This test is used for the rapid detection of the three most common autosomal trisomies: Patau's syndrome (Trisomy 13), Edward's Syndrome (Trisomy 18) and Down's Syndrome (Trisomy 21). Common X and Y Aneuploidies are also screened for, including Klinefelter's Syndrome (XXY) and Turner's Syndrome (XO).
  Availability: Samples are tested routinely during the testing laboratory's hours of operation.
Molecular Genetics reports are issued in hardcopy to requesting doctor only.
  Aliases/Synonyms: QFPCR,  
  Code: GQFA
  Handling Instructions (to laboratory): Send sample ambient.
  Hyperlink:
  Reference Interval:
Refer to report or laboratory


Collection Requirements
  Container: Sterile Container (STERILE),   and,   EDTA (LAVENDER),  
  Sample Type: Amniotic Fluid; CVS
  Minimum Collection Volume: 20mL Amniotic Fluid/CVS; 4mL Blood
  Collection Instructions: A maternal EDTA sample should also be collected.
Non-medicare rebateable item. Please contact testing laboratory for current pricing.


Processing Requirements
  Alternate Containers:
  Processing Instructions: The testing department should be contacted to arrange collection of sample from CSRA.
Store sample chilled if there will be a delay in processing.
  Minimum Assay Volume: 20mL Amniotic Fluid/CVS; 4mL Blood
  Stability: 72 hours ambient
  Transport Instructions (to testing laboratory): Send sample ambient.


Testing Locations
  Performed at:
Section Department Site Contact Phone
Cytogenetics Diagnostic Genomics QEII Medical Centre 6383 4241


Last Updated : 03-08-2023 13:47